| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.004.311 |
| Chemical and physical data | |
| Formula | C22H28BrNO3 |
| Molar mass | 434.374 g·mol−1 |
| 3D model (JSmol) | |
| |
| | |
Pipenzolate bromide is a pharmaceutical drug that has been studied as an antispasmodic agent and to treat peptic ulcer.12
Mechanism of action
Pipenzolate bromide acts as an antimuscarinic agent. It binds to muscarinic acetylcholine receptors as an antagonist therefore preventing acetylcholine from binding to the receptors.1
References
References
- "Pipenzolate". Inxight Drugs. National Center for Advancing Translational Sciences.
- Ivey KJ (January 1975). "Anticholinergics: do they work in peptic ulcer?". Gastroenterology. 68 (1): 154–166. doi:10.1016/S0016-5085(75)80062-X. PMID 1090477.